A. Presents COVID-19 symptoms including cough, fever, myalgias, headaches, loss of smell and taste B. Prior (last 30 days) or current (or planned use during the study period) use of hydroxychloroquine, chloroquine sulfate or azithromycin. C. Known history of prolonged QT syndrome. D. Known allergy or intolerance to hydroxychloroquine. E. Use of concomitant medications that are contraindicated with the use of hydroxychloroquine. F. Participation might not be beneficial, by investigator judgement.

A. Presents COVID-19 symptoms including cough, fever, myalgias, headaches, loss of smell and taste B. Prior (last 30 days) or current (or planned use during the study period) use of hydroxychloroquine, chloroquine sulfate or azithromycin. C. Known history of prolonged QT syndrome. D. Known allergy or intolerance to hydroxychloroquine. E. Use of concomitant medications that are contraindicated with the use of hydroxychloroquine. F. Participation might not be beneficial, by investigator judgement.